Nicole Swartz
Family · Missoula, MTNPI 1982968699
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.3%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 76.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $1,538 and has fallen 83.2% since, to $259 in 2025. Among family clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $55.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AbbVie$285
- Piramal Critical Care$109
- Teva Pharmaceuticals USA, Inc.$104
- Collegium Pharmaceutical, Inc.$101
- Supernus Pharmaceuticals, Inc.$27
- plus $99 from 6 others
What the payments were for
- Travel & lodging$1,70454%
- Food & beverage$1,38144%
- Education$542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 24 | $2,414 |
| AbbVie(2 entities) | 12 | $285 |
| Piramal Critical Care | 3 | $109 |
| Teva Pharmaceuticals USA, Inc. | 5 | $104 |
| Collegium Pharmaceutical, Inc. | 5 | $101 |
| Supernus Pharmaceuticals, Inc. | 2 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Amgen | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| GRT US Holding, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$813
- VANTA ADAPTIVESTIM$531
How this compares
$3,139 in reported general payments places this provider in the 95th percentile of 481 family providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 13 | $11,488 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 327 | $8,024 |
| OxycontinOxycodone Hcl | 14 | $5,676 |
| Gabapentin | 270 | $4,010 |
| Fentanyl | 38 | $3,547 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $2,937 |
| Morphine Sulfate ErMorphine Sulfate | 38 | $2,478 |
| Celecoxib | 66 | $2,263 |
| Oxycodone Hcl | 118 | $1,600 |
| Pregabalin | 126 | $1,573 |
| Buprenorphine Hcl | 25 | $1,573 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $1,216 |
| Topiramate | 43 | $880 |
| Tramadol Hcl | 123 | $815 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 16 | $791 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $101 | $11,48813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 481 family providers in Montana.
Other family in Missoula
- Michelle Weaver KnowlesMissoula$14K
- Shena OneillMissoula$4K
- Chelsey MillerMissoula$3K
- Tiffany FordMissoula$3K
- Matt McNuttMissoula$3K
- Mackenzie WestphalMissoula$3K
- Kari DebooMissoula$2K
- Sarah SlaterMissoula$2K
- Megan MorganMissoula$2K
- Susan McGeeMissoula$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.